---

$6.93

+0.0100 ( +0.15% ) 326.1K

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-11-12	Buy	2296.00	BAKER BROS. ADVISORS LP
2024-07-16	Sale	-300.00	Doshi Dipal
2024-07-16	Sale	-600.00	Sethuraman Natarajan
2024-07-10	Sale	-1758.00	WENTWORTH KORY JAMES
2024-06-26	Buy	285700.00	BAKER BROS. ADVISORS LP
2023-08-16	Sale	-1000.00	Doshi Dipal